iBio Supporting AzarGen Biotechnologies’ Development of a Rituximab Biosimilar
Go back to iBio Supporting AzarGen Biotechnologies’ Development of a Rituximab Biosimilar| IBIO, Inc. (NASDAQ: IBIO) | Delayed: 1.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.23 | 52 Week High | $0.80 | |||
| Open | $1.24 | 52 Week Low | $0.34 | |||
| Day High | $1.24 | P/E | N/A | |||
| Day Low | $1.21 | EPS | $-0.08 | |||
| Volume | 92,038 | |||||
